Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male; 2. Patients who plan to receive prostate biopsy for definite diagnosis due to elevated PSA, positive digital rectal examination or suspicious prostate cancer indicated by imaging; 3. Patients who volunteered to participate in the study after the existing diagnosis and treatment plan were informed.
Exclusion criteria
Exclusion criteria: 1. Patients who have previously received prostate puncture due to suspected prostate cancer; 2. Patients with metal implants and pacemakers in the body who cannot be detected by 3.0T MRI; 3. PSA > 100 ng/ml; 4. Concurrent with other serious systemic diseases, including severe respiratory, circulatory, nervous, mental, digestive, endocrine, immune, urinary and other system diseases, which the researcher believes may interfere with the treatment, evaluation and compliance of this study; Or other patients who have been determined by pre-anaesthetic assessment to be unable to tolerate general anesthesia; 5. Patients who are participating in other clinical trials or have participated in other clinical trials less than 1 year after completion; 6. Patients deemed unsuitable to participate in the clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| biopsy pathology; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical stage;biopsy needles;prostate imaging reporting and data system;prostate specific antigen; | — |
Countries
China
Contacts
The First Affiliated Hospital of Soochow University